Hisamitsu Pharmaceutical Co (FSE:4530) EV-to-OCF: (As of Aug. 04, 2026)

Hisamitsu Pharmaceutical Co  (FSE:4530) EV-to-OCF Explanation

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Hisamitsu Pharmaceutical Co's PE Ratio (TTM) for today is calculated as:

Hisamitsu Pharmaceutical Co's share price for today is 円3975.00.
Hisamitsu Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Nov. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円268.560.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Hisamitsu Pharmaceutical Co EV-to-OCF Related Terms

The historical data trend for Hisamitsu Pharmaceutical Co's EV-to-OCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hisamitsu Pharmaceutical Co EV-to-OCF Chart

Hisamitsu Pharmaceutical Co Annual Data
	Trend	Feb17	Feb18	Feb19	Feb20	Feb21	Feb22	Feb23	Feb24	Feb25	Feb26
EV-to-OCF		Get a 7-Day Free Trial					13.90	20.62	10.90	9.85	9.52

Hisamitsu Pharmaceutical Co Quarterly Data
	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25	May25	Aug25	Nov25	Feb26
EV-to-OCF	Get a 7-Day Free Trial															9.85	0.00	0.00	0.00	0.00

FSE:4530 vs AMPH, ESPR, NIKA: EV-to-OCF Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Hisamitsu Pharmaceutical Co's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hisamitsu Pharmaceutical Co EV-to-OCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hisamitsu Pharmaceutical Co's EV-to-OCF distribution charts can be found below:

* The bar in red indicates where Hisamitsu Pharmaceutical Co's EV-to-OCF falls into.

Hisamitsu Pharmaceutical Co EV-to-OCF Calculation

Hisamitsu Pharmaceutical Co's EV-to-OCF for today is calculated as:

Hisamitsu Pharmaceutical Co's current Enterprise Value is 円311,836 Mil.
Hisamitsu Pharmaceutical Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Nov. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hisamitsu Pharmaceutical Co Business Description